Skip to main content
All lobbying filings

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Lobbying for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION · patient advocacy organization for individuals suffering from a rare disease

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $10,000.00 income · posted Apr 15, 2026

Official filing document

 Bills named in this filing 1
  • HR 7148
    Consolidated Appropriations Act, 2026
 Lobbying activity 2
Defense

Hereditary Hemorrhagic Telanglectasia (HHT)

Health Issues

H.R. 7148, FY 2026 Consolidated Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT) and Funding for National HHT Center of Excellence Program; H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R./S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem